None of the three compounds have human safety data in pregnancy or breastfeeding, and they are not FDA-approved
The 59-year-old nurse began taking Zepbound in May 2025 after struggling with her health, low energy levels and stubborn weight gain
Documentation of the discontinuation plan, including reasons for stopping, transition strategies, and monitoring schedule, should be clearly communicated between patient and provider to ensure coordinated care and optimal outcomes
Studies also show patients with heart conditions who better adhere to their medication prescriptions have lower risks of NAION than those who don't
Otherwise, skip the missed dose
The schedule mirrors the clinical-trial protocols that drove substantial weight loss around 20% of body weight over 72 weeks on the 15 mg dose [2] while holding gastrointestinal effects down through gradual escalation [1] [4]